{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/biotech-challenges-and-crucial-role-cro-partnerships#webpage",
"url": "https://www.fortrea.com/insights/biotech-challenges-and-crucial-role-cro-partnerships",
"name": "Biotech challenges and the crucial role of CRO partnerships",
"description": "This Fortrea white paper explores challenges affecting biotech clinical trials and the growing role of CRO partnerships in supporting clinical-stage biotech companies throughout clinical development programs. The content focuses on biotech clinical development strategies, biotech outsourcing strategy considerations, regulatory strategy for biotechs, operational scalability, and flexible support models designed to accelerate biotech clinical development across multiple trial phases. The white paper highlights challenges associated with biotech clinical research, resource limitations, funding pressures, operational complexity, and managing biotech phases of clinical trials within evolving development environments. Fortrea discusses how full-service CRO support and hybrid CRO delivery models can help support biotech phase 3 clinical trials, improve operational efficiency, and strengthen clinical development execution across early-stage biotech development and later-stage programs. By integrating CRO partnership strategies with biotech clinical development planning and operational support approaches, the white paper provides insights into improving biotech clinical trial execution and addressing biotech drug development challenges."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Biotech challenges and the crucial role of CRO partnerships",
"item": "https://www.fortrea.com/insights/biotech-challenges-and-crucial-role-cro-partnerships"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/biotech-challenges-and-crucial-role-cro-partnerships#whitepaper",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/biotech-challenges-and-crucial-role-cro-partnerships#webpage"
},
"headline": "Biotech Clinical Trials and CRO Partnerships for Clinical Development Success | Fortrea White Paper",
"description": "This Fortrea white paper explores challenges affecting biotech clinical trials and the growing role of CRO partnerships in supporting clinical-stage biotech companies throughout clinical development programs. The content focuses on biotech clinical development strategies, biotech outsourcing strategy considerations, regulatory strategy for biotechs, operational scalability, and flexible support models designed to accelerate biotech clinical development across multiple trial phases. The white paper highlights challenges associated with biotech clinical research, resource limitations, funding pressures, operational complexity, and managing biotech phases of clinical trials within evolving development environments. Fortrea discusses how full-service CRO support and hybrid CRO delivery models can help support biotech phase 3 clinical trials, improve operational efficiency, and strengthen clinical development execution across early-stage biotech development and later-stage programs. By integrating CRO partnership strategies with biotech clinical development planning and operational support approaches, the white paper provides insights into improving biotech clinical trial execution and addressing biotech drug development challenges.",
"genre": "White Paper",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2025-09-04",
"dateModified": "2025-09-04",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2025-09/Biotech-challenges-crucial-role-of-cro-partnerships.pdf",
"encodingFormat": "application/pdf"
}
}
]
}